Immunic Inc [NASDAQ: IMUX] traded at a low on Wednesday, posting a -22.65 loss after which it closed the day’ session at $0.99.
The results of the trading session contributed to over 8828918 shares changing hands. Over the past one week, the price volatility of Immunic Inc stands at 15.01% while the volatility over the past one month is 11.09%.
The market cap for IMUX stock reached $94.87 million, with 95.82 million shares outstanding and 92.92 million shares in the current float. Compared to the average trading volume of 720.33K shares, IMUX reached a trading volume of 8828918 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Immunic Inc [IMUX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IMUX shares is $13.26 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IMUX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Immunic Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 25, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on November 25, 2024, representing the official price target for Immunic Inc stock. Previously, the target price had yet another raise to $5, while Leerink Partners analysts kept a Outperform rating on IMUX stock.
The Average True Range (ATR) for Immunic Inc is set at 0.11 The Price to Book ratio for the last quarter was 4.84, with the Price to Cash per share for the same quarter was set at 0.37.
How has IMUX stock performed recently?
Immunic Inc [IMUX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.99. With this latest performance, IMUX shares dropped by -9.17% in over the last four-week period, additionally sinking by -28.77% over the last 6 months – not to mention a drop of -18.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IMUX stock in for the last two-week period is set at 45.80, with the RSI for the last a single of trading hit 44.30, and the three-weeks RSI is set at 46.54 for Immunic Inc [IMUX]. The present Moving Average for the last 50 days of trading for this stock 1.0987, while it was recorded at 1.1280 for the last single week of trading, and 1.2346 for the last 200 days.
Immunic Inc [IMUX]: Deeper insight into the fundamentals
Immunic Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.77 and a Current Ratio set at 1.77.
Insider trade positions for Immunic Inc [IMUX]
There are presently around $56.01%, or 56.57%% of IMUX stock, in the hands of institutional investors. The top three institutional holders of IMUX stocks are: BVF INC/IL with ownership of 8.9 million shares, which is approximately 9.15%. AVIDITY PARTNERS MANAGEMENT LP, holding 8.9 million shares of the stock with an approximate value of $$9.88 million in IMUX stocks shares; and AVIDITY PARTNERS MANAGEMENT LP, currently with $$8.1 million in IMUX stock with ownership which is approximately 7.4954%.
